Utility of immunohistochemistry for CD99 in the identification of matrix-producing carcinoma of the breast [1]

Histopathology

Volumn 42, Issue 3, 2003, Pages 300-301

  Walker, J A ^a   Carder, P J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CD99 ANTIGEN; VIMENTIN;

ADULT; BONE BIOPSY; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER SURGERY; CASE REPORT; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; METASTASIS; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL ADHESION MOLECULES; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; SPINAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037343591     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2003.15361.x     Document Type: Letter

References (3)

1. Milanezi F, Pereira EM, Ferreira FV, Leitao D, Schmitt FC. CD99/MIC-2 surface protein expression in breast carcinomas. Histopathology 2001: 39; 578-583.
2. Ostrowski J, Horgan K, Kraus T, Quinn CM. Monophasic sarcomatoid carcinoma of the breast. Histopathology 1998: 32; 184-186.
3. Weidner N, Tjow J. Immunohistochemical profile of monoclonal antibody 013; antibody that recognises glycoprotein p30/32. MIC2 and is useful in diagnosing Ewings sarcoma and peripheral neuroepithelioma. Am. J. Surg. Pathol. 1994: 18; 486-494.